Your browser doesn't support javascript.
loading
Donepezil 23 mg in Asian patients with moderate-to-severe Alzheimer's disease.
Han, S-H; Lee, J-H; Kim, S Y; Park, K W; Chen, C; Tripathi, M; Dash, A; Kubota, N.
Affiliation
  • Han SH; Department of Neurology, Konkuk University Hospital, Seoul, South Korea.
  • Lee JH; Department of Neurology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, South Korea.
  • Kim SY; Department of Neurology, Clinical Neuroscience Center & Neurology, Seoul National University Bundang Hospita, Gyeonggi-do, South Korea.
  • Park KW; Department of Neurology, Dong-A University College of Medicine, Dong-A University Hospital, Busan, South Korea.
  • Chen C; Department of Pharmacology, National University of Singapore and Memory Aging and Cognition Center, National University Health System, Singapore, Singapore.
  • Tripathi M; Department of Neurology, Neuroscience Centre, AIIMS, New Delhi, India.
  • Dash A; Regional Medical Advisor, Eisai Pharmaceuticals India Pvt. Ltd., Mumbai, India.
  • Kubota N; Clinical Development Eisai Co. Ltd., Tokyo, Japan.
Acta Neurol Scand ; 135(2): 252-256, 2017 Feb.
Article in En | MEDLINE | ID: mdl-26923256
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Piperidines / Severity of Illness Index / Cholinesterase Inhibitors / Asian People / Alzheimer Disease / Indans Type of study: Clinical_trials Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Year: 2017 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Piperidines / Severity of Illness Index / Cholinesterase Inhibitors / Asian People / Alzheimer Disease / Indans Type of study: Clinical_trials Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Year: 2017 Type: Article